AGTX
Price
$0.02
Change
-$0.01 (-33.33%)
Updated
Jul 23 closing price
Capitalization
841.41K
RLAY
Price
$3.74
Change
+$0.06 (+1.63%)
Updated
Jul 25 closing price
Capitalization
641.2M
16 days until earnings call
Interact to see
Advertisement

AGTX vs RLAY

Header iconAGTX vs RLAY Comparison
Open Charts AGTX vs RLAYBanner chart's image
Agentix
Price$0.02
Change-$0.01 (-33.33%)
Volume$7K
Capitalization841.41K
Relay Therapeutics
Price$3.74
Change+$0.06 (+1.63%)
Volume$3.27M
Capitalization641.2M
AGTX vs RLAY Comparison Chart in %
Loading...
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGTX vs. RLAY commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGTX is a Hold and RLAY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (AGTX: $0.02 vs. RLAY: $3.74)
Brand notoriety: AGTX and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGTX: 20% vs. RLAY: 176%
Market capitalization -- AGTX: $841.41K vs. RLAY: $641.2M
AGTX [@Biotechnology] is valued at $841.41K. RLAY’s [@Biotechnology] market capitalization is $641.2M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGTX’s FA Score shows that 1 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • AGTX’s FA Score: 1 green, 4 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than AGTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGTX’s TA Score shows that 3 TA indicator(s) are bullish while RLAY’s TA Score has 3 bullish TA indicator(s).

  • AGTX’s TA Score: 3 bullish, 2 bearish.
  • RLAY’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AGTX is a better buy in the short-term than RLAY.

Price Growth

AGTX (@Biotechnology) experienced а -28.69% price change this week, while RLAY (@Biotechnology) price change was +6.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

AGTX is expected to report earnings on Jul 16, 2025.

RLAY is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($641M) has a higher market cap than AGTX($841K). RLAY YTD gains are higher at: -9.223 vs. AGTX (-88.167). AGTX has higher annual earnings (EBITDA): -352.07K vs. RLAY (-373.07M). RLAY has more cash in the bank: 710M vs. AGTX (8.27K). AGTX has less debt than RLAY: AGTX (198K) vs RLAY (47.2M). RLAY has higher revenues than AGTX: RLAY (7.68M) vs AGTX (0).
AGTXRLAYAGTX / RLAY
Capitalization841K641M0%
EBITDA-352.07K-373.07M0%
Gain YTD-88.167-9.223956%
P/E RatioN/AN/A-
Revenue07.68M-
Total Cash8.27K710M0%
Total Debt198K47.2M0%
FUNDAMENTALS RATINGS
AGTX: Fundamental Ratings
AGTX
OUTLOOK RATING
1..100
82
VALUATION
overvalued / fair valued / undervalued
1..100
3
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
97
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AGTXRLAY
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
88%
Momentum
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
63%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
73%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
62%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
82%
Declines
ODDS (%)
N/A
Bearish Trend 12 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
60%
Bullish Trend 2 days ago
72%
View a ticker or compare two or three
Interact to see
Advertisement
AGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYTSX54.930.67
+1.23%
Rydex Transportation A
CSMVX41.820.43
+1.04%
Congress Small Cap Growth Retail
IVITX19.610.11
+0.56%
VY® Invesco Growth and Income S2
TMCJX50.600.21
+0.42%
Touchstone Mid Cap C
AIOIX10.97-0.01
-0.09%
American Century International Opps Inv

AGTX and

Correlation & Price change

A.I.dvisor tells us that AGTX and RLAY have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AGTX and RLAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGTX
1D Price
Change %
AGTX100%
N/A
RLAY - AGTX
32%
Poorly correlated
+1.63%
RVMD - AGTX
28%
Poorly correlated
+1.84%
SKYE - AGTX
23%
Poorly correlated
-2.49%
ALGS - AGTX
23%
Poorly correlated
+2.47%
BCYC - AGTX
22%
Poorly correlated
+1.16%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with XNCR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
+1.63%
XNCR - RLAY
52%
Loosely correlated
N/A
BCYC - RLAY
48%
Loosely correlated
+1.16%
IMNM - RLAY
48%
Loosely correlated
-3.29%
BDTX - RLAY
47%
Loosely correlated
-4.81%
SMMT - RLAY
47%
Loosely correlated
+3.99%
More